December 4, 2014 - ASM Signs onto Letter to the FDA the Regarding Collection and Reporting of Antimicrobial Data
The ASM joined 27 other organizations in sending a letter to Dr. Margaret Hamburg, Commissioner of the Food and Drug Administration regarding implementation of the National Action Plan on Combating Antimicrobial Resistance.
November 25, 2014 - ASM Signs onto Letter Regarding FY 2015 Appropriations
The ASM signed onto a letter from the Energy Sciences Coalition urging Congress to complete work on the FY 2015 Appropriations process and to increase funding for critical scientific research supported by the Department of Energy’s Office of Science and the Advanced Research Projects Agency for Energy (ARPA-E).
November 12, 2014 - ASM Supports FY 2015 Omnibus Appropriations Bill
The ASM sent a letter to members of Congress supporting passage of an FY 2015 Omnibus Appropriations bill to provide sustained and predictable federal funding for life science research and public health programs.
November 7, 2014 - ASM Supports Emergency Funding to Combat Ebola Virus Outbreak
The ASM sent a letter to members of Congress supporting the Administration's $6.18 billion emergency funding request to combat the Ebola Virus outbreak.
October 27, 2014 - ASM Sends Letter to OMB Regarding Antibiotic Resistance Funding
The ASM and 52 other organizations signed a letter to Shaun Donovan, OMB Director urging the OMB to provide the resources necessary to implement the President’s Council of Advisors on Science and Technology (PCAST) recommendations to combat antibiotic resistance.
October 27, 2014 -ASM Testifies Before the Federal Experts Security Advisory Panel on Issues Related to Biosafety and Biosecurity
Ronald Atlas, Ph.D., Chair of the Public and Scientific Affairs Board testified before the Federal Experts Security Advisory Panel. To strengthen US Government oversight for work with infectious agents, including (but not limited to) Biological Select Agents and Toxins (BSAT), the FESAP has undertaken a comprehensive federal review that will result in specific recommendations to strengthen the government's biosafety and biosecurity practices and oversight system for federally-funded activities, consistent with the need to realize the public health and security benefits of such work. The ASM will address the following tasks in its testimony: 1. Identify needs and gaps and make recommendat ions to optimize biosa fety , biosecurity, oversight , and inventory management and control for BSAT, 2. Identify actions and any regulatory changes necessary to improve biosafety and biosecurity, 3. Identify an approach to determine the appropriate number of high containment U.S. laboratories required to possess, use, or transfer BSAT.
October 2, 2014 - ASM Provides Ebola Resources for Clinical Laboratory Scientists
The ASM sent out a notice to clinical members about Ebola Virus resources.
September 23, 2014 - ASM Letter to the US HHS Concerning Scientific Resources in Response to the Ebola Virus Outbreak
The ASM sent a letter to Sylvia M. Burwell, Secretary US Department of Health & Human Services with recommendations concerning scientific resources that are needed in response to the Ebola virus outbreak.
September 23, 2014 - ASM Letter to the UN Concerning Scientific Resources in Response to the Ebola Virus Outbreak
The ASM sent a letter to David Nabarro, M.D., Senior United Nations System Coordinator for Ebola Virus Disease with recommendations concerning scientific resources that are needed in response to the Ebola virus outbreak.
September 23, 2014 - ASM Statement on National Strategy to Combat Antibiotic Resistant Bacteria
The ASM sent a statement on the National Strategy to Combat Antibiotic Resistant Bacteria, which was announced by President Obama on September 18, 2014 to ASM members, Congress and representatives of various federal agencies.
September 17, 2014 - ASM Statement on Ebola Response
The ASM sent a statement to members of Congress regarding the response to the Ebola outbreak in Western Africa encouraging additional support for research and public health programs.
September 2, 2014 - USG Communications about Ensuring Biosafety in US Laboratories
The ASM sent an e-mail to ASM members regarding US Government communications about ensuring biosafety in US laboratories. The e-mail includes links to a White House memo and an NIH notice.
September 2, 2014 - ASM Provides Comments on CME and LCD
ASM commented on “Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, Access to Identifiable Data for the Center for Medicare and Medicaid Innovation Models & Other Revisions to Part B for CY 2015” as published in the July 11 Federal Register. The comments focus on proposed changes in continuing medical education (CME) and the local coverage determination (LCD) process for laboratory testing.
August 25, 2014 - ASM Statement: What is in your Laboratory Freezer?
ASM sent a statement out to ASM members reminding them to practice safe "laboratory housekeeping."
August 20, 2014 - ASM Comments to FDA on Rapid Influenza Test Classification
The ASM commented on an FDA proposal to reclassify antigen based rapid influenza virus antigen detection test systems intended to detect influenza virus directly from clinical specimens.
July 31, 2014 - ASM Statement on Dual Use Research of Concern and Biosafety
The ASM sent a statement to ASM members on Dual Use Research of Concern and Biosafety.
July 30, 2014 - Historical Background Related to Select Agents
July 21, 2014 - ASM Statement on Recent Biosafety Lapses
The ASM sent the following statement to ASM members regarding the recent biosafety lapses.
July 21, 2014 - ASM Letter Regarding the Accelerating Biomedical Research Act
The ASM sent a letter to Senator Tom Harkin thanking him for the Accelerating Biomedical Research Act and his leadership regarding funding for the National Institutes of Health.
July 14, 2014 - ASM Provides Comments on the Protecting Access to Medicare Act to CMS
ASM provided comments to the Centers for Medicare & Medicaid Services (CMS) regarding Section 1834A, “Improving Policies for Clinical Diagnostic Laboratory Tests,” added to the Social Security Law by the Protecting Access to Medicare Act of 2014 (PAMA).
July 14, 2014 - Payment Determinations for Calendar Year 2015 for New Clinical Laboratory Tests
The ASM presented recommendations to the Centers for Medicare & Medicaid Services at its annual public meeting on payment levels for new tests to be included in the 2015 Clinical Laboratory Fee Schedule.
June 19, 2014 - CNSF Statement on Senate FY 2015 Commerce, Justice, Science Appropriations Bill
The ASM signed on to a Coalition for National Science Funding (CNSF) statement supporting the FY 2015 Commerce, Justice, Science Appropriations bill passed by the Senate Appropriations committee that placed a high priority on basic science funding at the National Science Foundation (NSF), and urged members of the full Senate to support funding levels in the bill. A similar letter was sent to the House appropriations committee in May and can is available here.
June 16, 2014 - ASM Letter Concerning DOE Authorization Bill
The ASM sent a letter to the House Science, Space and Technology Committee regarding the DOE authorization bill that would make significant cuts in R&D funding for the energy and environmental sciences.
June 10, 2014 - ASM Signs onto a Letter Regarding the 21st Century Cures Initiative and the Antibiotic Development to Advance Patient Treatment (ADAPT) Act
The ASM joined 23 other organizations in signing a letter to the House Energy & Commerce Committee urging them to act promptly on the Antibiotic Development to Advance Patient Treatment (ADAPT) Act, which would carry out the PCAST recommendation to establish a new limited population approval pathway for antibiotics to treat serious or life-threatening infections where an unmet medical need exists.
May 28, 2015 - CNSF Statement on FY 2015 House Commerce, Justice, Science Appropriations Bill
The Coalition for National Science Funding released a statement comending the House Commerce, Justice, Science and Related Agencies Appropriations Subcommittee for preparing an appropriations bill that puts a high priority on funding science. Chairman Wolf also released a statement about the CJS bill that you can read by clicking here.
April 28, 2014 - ASM Signs onto Innovation Testimony
The ASM joined 50 other organizations in submitting testimony for the Senate Appropriations Committee’s April 29 hearing, “Driving Innovation Through Federal Investments.” There is also an infographic that highlights various aspects of the innovation deficit. The infographic is available at http://www.innovationdeficit.org.
April 18, 2014 – ASM Signs onto Letter Urging Support for Antibiotic Resistance Initiative
ASM joined 26 other organizations in signing a letter to the Chairs and Ranking Members of the House and Senate Appropriations Committee on Labor, HHS and Education. The letter urged them to appropriate the $30 million included in the Fiscal Year 2015 President’s Budget Request for the Centers for Disease Control and Prevention (CDC) Detect and Protect Against Antibiotic Resistance Initiative.
April 1, 2014 – Coalition Letter Supporting Countermeasure Funding
The ASM has endorsed the Informal Coalition on Biodefense and Emergency Health Preparedness letter to the House and Senate LHHS Appropriations Subcommittees regarding FY 2014 appropriations supporting programs critical to the Nation’s preparedness against chemical, biological, radiological, and nuclear (CBRN) threats.
March 19, 2014 - ASM Endorses the American Cures Act
The ASM sent a letter to Senator Richard Durbin (D-IL) endorsing the bill which would create a trust fund to support a mandatory funding stream for biomedical research supported by the National Institutes of Health and other federal agencies involved in biomedical research.
March 13, 2014 - Coalition for National Science Funding (CNSF) Letter to Congress
The ASM signed on to a CNSF letter sent to members of the House Committee on Science, Space and Technology and to the Subcommittee on Research and Technology expressing concerns with H.R.4186, the Frontiers in Research, Science, Technology (FIRST) Act of 2014.
February 26, 2014 - CLC Letter to Congressional Leadership Regarding Laboratory Fee Reimbursement
ASM endorsed a Clinical Laboratory Coalition (CLC) letter sent to both the House and Senate Leadership, urging them not to reduce laboratory fee reimbursement for FY 2014. (Senate Version)
February 14, 2014 - Letter to Farm Bill Conferees
The ASM endorsed a letter written by the National Coalition for Food and Agriculture (NationalC-FAR), thanking the Farm Bill conferees for authorizing the development of a Foundation for Food and Agriculture Research (FFAR) in the 2014 Farm Bill.
February 4, 2014 - SoAR Letter to Congressional Leadership
ASM endorsed a Supporters of Agricultural Research (SoAR) letter sent to the chairs and ranking members of both the House and Senate agriculture appropriations subcommittees, thanking them for funding AFRI with $316million for FY 2014.
January 17, 2014 - ASM Statement on the FY 2014 Omnibus Appropriations Bill
The ASM released a statement about the passage of the "Consolidated Appropriations Act of 2014."
January 13, 2014 - ASM Comments on Government Travel Restrictions
The ASM submitted a letter to the Senate Committee on Homeland Security and Governmental Affairs as part of the hearing record for its January 14 hearing entitled “Examining Conference and Travel Spending Across the Federal Government.”
January 1, 2014 - Agriculture and Food Research Initiative Coalition Letter
AFRI Coalition Letter sent to the House and Senate Appropriations Committees urging them to fund AFRI with at least $316 million in FY 2014.